By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panel is divided on the choice between IXUS and IEMG, with concerns about geopolitical risks, concentration, and mean-reversion, but also seeing potential in EM growth and thematic semiconductor exposure.
Risk: Geopolitical risks, particularly around China-Taiwan relations and U.S. export controls, as well as potential mean-reversion in EM and single-stock concentration risks.
Opportunity: Potential outsized upside from an EM-led growth cycle driven by China reopening, India-style reforms, and commodity demand, as well as thematic semiconductor exposure.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
iShares Core MSCI Emerging Markets ETF provides concentrated exposure to developing economies with higher recent returns but also greater historical drawdowns than iShares Core MSCI Total International Stock ETF.
iShares Core MSCI Total International Stock ETF offers a lower expense ratio and broader diversification across both developed and emerging markets compared to the more focused iShares Core MSCI Emerging Markets ETF.
iShares Core MSCI Total International Stock ETF has provided a higher distribution yield and better risk-adjusted growth over the last five years than iShares Core MSCI Emerging Markets ETF.
The iShares Core MSCI Total International Stock ETF (NASDAQ:IXUS) provides broad global exposure, whereas the iShares Core MSCI Emerging Markets ETF (NYSEMKT:IEMG) targets specific growth and volatility within developing economies.
Both funds offer low-cost access to non-U.S. equities, yet they serve different roles in a portfolio. While IXUS covers the entire international landscape, IEMG focuses exclusively on emerging markets, leading to distinct risk profiles and sector concentrations for investors looking to diversify outside domestic borders.
| Metric | IXUS | IEMG | |---|---|---| | Issuer | iShares | iShares | | Expense ratio | 0.07% | 0.09% | | 1-yr return (as of May 6, 2026) | 35.6% | 52.1% | | Dividend yield | 2.9% | 2.2% | | Beta | 0.77 | 0.72 | | AUM | $56.5 billion | $155.0 billion |
Beta measures price volatility relative to the S&P 500; beta is calculated from five-year monthly returns. The 1-yr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.
The iShares Core MSCI Total International Stock ETF is slightly more affordable with a 0.07% expense ratio compared to 0.09% for the iShares Core MSCI Emerging Markets ETF. Investors may also find the 2.9% distribution yield of the international fund more attractive than the 2.2% offered by the emerging markets fund.
| Metric | IXUS | IEMG | |---|---|---| | Max drawdown (5 yr) | (30.1%) | (37.1%) | | Growth of $1,000 over 5 years (total return) | $1,513 | $1,437 |
The iShares Core MSCI Emerging Markets ETF (NYSEMKT:IEMG) focuses on developing economies, with technology representing 23%, financials at 18%, and consumer discretionary at 7% of the portfolio. Its largest positions include Taiwan Semiconductor Manufacturing at 12.56%, Samsung Electronics at 5.39%, and SK Hynix at 3.87%. Launched in 2012, this fund holds 2,661 securities and has a trailing-12-month dividend of $1.85 per share.
In contrast, the iShares Core MSCI Total International Stock ETF (NASDAQ:IXUS) provides broader reach with 4,160 holdings and covers both developed and emerging regions. Its sector mix leans toward financial services at 23%, followed by industrials and technology at 16% each. Its top holdings include Taiwan Semiconductor Manufacturing at 4.11%, Samsung Electronics at 1.77%, and ASML Holding at 1.31%. Also launched in 2012, it has paid $2.74 per share over the trailing 12 months.
For more guidance on ETF investing, check out the full guide at this link.
For investors looking beyond U.S. borders, the choice often comes down to how much risk they want to take on. Developed markets such as Japan, the U.K., France, and Germany offer international diversification with relatively familiar regulatory and economic environments. Emerging markets of China, India, Taiwan, and South Korea offer higher growth potential but with greater volatility, currency risk, and political uncertainty.
IXUS captures both worlds in a single fund, holding over 4,000 stocks across developed and emerging markets outside the U.S. About three-quarters of the portfolio sits in developed markets, with emerging markets making up the remainder. IEMG concentrates entirely on the emerging markets portion of that equation, going deeper into countries and companies that IXUS holds only partially.
The fee difference between them is negligible. The real consideration is portfolio fit. Investors who want straightforward, all-in-one international exposure will find IXUS the more balanced choice. Those who already hold developed market exposure and want to tilt specifically toward emerging market growth — accepting the added volatility — will find IEMG the more targeted vehicle.
Before you buy stock in iShares - iShares Core Msci Emerging Markets ETF, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and iShares - iShares Core Msci Emerging Markets ETF wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $471,827! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,319,291!
Now, it’s worth noting Stock Advisor’s total average return is 986% — a market-crushing outperformance compared to 207% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of May 10, 2026. *
Sara Appino has positions in Taiwan Semiconductor Manufacturing. The Motley Fool has positions in and recommends Taiwan Semiconductor Manufacturing. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"IEMG is less a diversified emerging markets play and more a high-beta bet on the semiconductor supply chain, which carries significant geopolitical tail risk not captured by historical volatility metrics."
The article frames the choice between IXUS and IEMG as a simple risk-tolerance trade-off, but it misses the critical impact of geopolitical concentration. IEMG is effectively a bet on the 'Silicon Shield' of Taiwan and South Korean semiconductor dominance, with TSM alone representing over 12% of the fund. While the 52.1% one-year return looks enticing, it masks extreme sensitivity to China-Taiwan relations and U.S. export controls. IXUS is the more prudent 'core' holding, yet even then, investors are buying heavy exposure to European financials and industrials that have struggled with structural stagnation. Neither fund offers a true growth hedge against U.S. tech dominance; they are essentially beta-plays on global manufacturing cycles.
If the global semiconductor super-cycle continues to widen, IEMG’s extreme concentration in TSM and SK Hynix will continue to outperform broad international indices by an order of magnitude, rendering 'diversification' a drag on returns.
"IEMG's heavy tilt to leading Asian semis like TSM positions it to capture EM's growth resurgence, outweighing short-term volatility for patient investors."
The article favors IXUS for its balance, lower drawdown (-30% vs -37%), higher 5-year growth ($1,513 vs $1,437 per $1,000), and 2.9% yield, but glosses over IEMG's explosive 52% 1-year return vs 35%—fueled by overweight in AI/semiconductor giants like TSM (12.6% vs 4.1%), Samsung (5.4% vs 1.8%), and SK Hynix (3.9%). IEMG's $155B AUM dwarfs IXUS's $56B, ensuring liquidity, and the 0.02% fee gap is trivial. EM's historical cheap valuations (unmentioned) and Asia tech momentum suggest re-rating potential if growth sustains, despite China risks.
IEMG's edge is recent and cyclical; its deeper drawdowns and EM currency/political risks (e.g., Taiwan tensions) could amplify losses if global growth slows or USD strengthens, reverting to IXUS's steadier profile.
"IEMG's 52% YoY return masks that IXUS outperformed over 5 years with lower volatility, suggesting the current EM rally is cyclical mean-reversion attracting late retail capital into a concentrated, crowded position."
The article frames this as a simple risk-return tradeoff, but the data contradicts its own narrative. IXUS returned 35.6% YoY with a 0.77 beta, while IEMG returned 52.1% with a 0.72 beta—lower volatility, higher returns. Over 5 years, IXUS ($1,513 on $1k) beat IEMG ($1,437), yet IEMG's 37.1% max drawdown versus IXUS's 30.1% suggests the recent outperformance is mean-reversion in EM after years of underperformance, not a structural advantage. The article doesn't address why IEMG's $155B AUM dwarfs IXUS's $56.5B despite inferior 5-year returns—signaling retail chasing recent performance into a crowded trade.
If EM re-rates sustainably higher due to AI adoption in semiconductors (TSMC, Samsung dominance) or China stimulus, IEMG's concentration becomes an asset, not a liability, and its recent outperformance could extend for years rather than reverse.
"The next regime appears more EM-friendly, making IEMG better positioned to outperform IXUS over the medium term despite higher volatility."
The article frames IXUS as the balanced, low-variance choice versus IEMG's EM tilt, citing lower fees and broader reach. The strongest counterview is that an EM-led growth cycle—driven by China reopening, India-style reforms, and commodity demand—could unlock outsized upside for IEMG, while IXUS may curb gains with its developed-market exposure. Currency moves and policy risk in EM add volatility the piece downplays. The 1-year outperformance of IEMG hints at momentum rather than a structural advantage for IXUS; tail risks in EM (debt, inflation, geopolitics) could also swing more violently than depicted.
If EMs fail to accelerate, IXUS's diversified, developed-heavy exposure could outperform. Also, persistent US strength and dollar strength could dampen non-U.S. equity returns, skewing the expected advantage toward IXUS.
"IEMG functions as a concentrated semiconductor thematic fund rather than a traditional diversified EM index."
Claude, your assessment of AUM as a proxy for 'retail chasing' ignores institutional flows. Large-scale capital is moving into IEMG specifically to capture the AI hardware supply chain, not just for broad EM beta. The 12% TSM concentration isn't a bug; it is a feature for funds seeking direct exposure to the only viable alternative to U.S.-based hyperscaler capex. IEMG is essentially a thematic semiconductor play disguised as an index fund, not a diversified EM vehicle.
"IEMG's TSM-heavy positioning amplifies reversal risks from geopolitical tensions and US onshoring, undermining institutional flow arguments."
Gemini, your defense of TSM concentration as an institutional 'feature' overlooks flow fragility: 2022 saw $20B+ outflows from EM ETFs amid Taiwan fears, per Morningstar data, erasing AUM gains. US CHIPS Act (>$50B allocated) is subsidizing domestic fabs (Intel Arizona, TSMC itself), diluting the 'Silicon Shield' moat. IEMG's 20% EM tech overweight (vs IXUS ~8%) risks sharper mean-reversion if AI capex plateaus.
"CHIPS Act subsidies are a structural headwind to TSM's moat that IEMG's concentration thesis hasn't priced in."
Grok's CHIPS Act point is underexplored. $50B+ domestic subsidies don't just dilute TSM's moat—they structurally redirect capex away from Taiwan over 5-7 years. Gemini frames TSM concentration as institutional demand for 'the only alternative,' but that thesis breaks if US fabs reach cost parity. IEMG's outperformance may be cyclical AI hype, not structural. The 2022 outflow precedent Grok cited matters more than current AUM size.
"IEMG's concentration in TSM and peers makes it a riskier bet on AI-capex than IXUS, despite EM policy support."
Claude, your focus on mean-reversion ignores a key risk: EM policy support and AI-capex cycles can keep IEMG's tech tilt resilient longer, but they also create a single-stock concentration shock. With roughly 12–13% in TSM and heavy SK Hynix exposure, a 1–2 quarter AI slowdown could drive outsized drawdowns, more than IXUS's diversified exposure. The real test is how EM liquidity and USD moves interact with capex cycles.
The panel is divided on the choice between IXUS and IEMG, with concerns about geopolitical risks, concentration, and mean-reversion, but also seeing potential in EM growth and thematic semiconductor exposure.
Potential outsized upside from an EM-led growth cycle driven by China reopening, India-style reforms, and commodity demand, as well as thematic semiconductor exposure.
Geopolitical risks, particularly around China-Taiwan relations and U.S. export controls, as well as potential mean-reversion in EM and single-stock concentration risks.